#Forbes Kirsten Gillibrand Sounds Alarm On Pitfalls Of Exclusively Relying On Domestic Drug Production
Kirsten Gillibrand Sounds Alarm On Pitfalls Of Exclusively Relying On Domestic Drug Production
At a Senate Aging Committee hearing on Wednesday, Sen. Kirsten Gillibrand (D-NY) raised concerns around potential supply chain risks of solely depending on U.S. producers for prescription drug components.
Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:
https://ift.tt/iroLYAl
Stay Connected
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: https://ift.tt/EGUDj8K
More From Forbes: http://forbes.com
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
コメントを送信